Abstract
Intranasal oxytocin for apathy in people with frontotemporal dementia (FOXY): a multicentre, randomised, double-blind, placebo-controlled, adaptive, crossover, phase 2a/2b superiority trial.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have